- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2017-05-24 20:05:00
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2017-05-24 20:05:00
- SEC Url:
- Form 4 Filing
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1033409||N Fredric Eshelman||C/o G1 Therapeutics, Inc. |
79 T.w. Alexander Drive
Research Triangle Park NC 27709
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Common Stock||Acquisiton||2017-05-22||3,139,151||$0.00||3,139,151||No||4||C||Indirect||See Footnote|
|Common Stock||Acquisiton||2017-05-22||300,000||$15.00||3,439,151||No||4||P||Indirect||See Footnote|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Series B Preferred Stock||Disposition||2017-05-22||6,893,224||$0.00||2,297,740||$0.00|
|Common Stock||Series C Preferred Stock||Disposition||2017-05-22||2,524,233||$0.00||841,411||$0.00|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series B Preferred Stock and the Series C Preferred Stock converted to Common Stock on a 1-for-3 basis.
- Eshelman Ventures, LLC is the record holder of the securities. Dr. Fredric Eshelman is the founder and principal of Eshelman Ventures, LLC and may be deemed to beneficially own the securities held by Eshelman Ventures, LLC. Dr. Eshelman disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- Reflects shares Eshelman Ventures, LLC purchased in the initial public offering at the initial public offering price of $15.00 per share.
- The Series B Preferred Stock and the Series C Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date.